Latest Headlines

May 29, 2026

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

Conexiant

May 28, 2026

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

Conexiant

May 27, 2026

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

Conexiant

May 27, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Conexiant

May 27, 2026

Biologics Commonly Used in Cutaneous Crohn Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn disease.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

May 22, 2026

3 Medical Routines That Older People May Not Need

“The treatment may be more burdensome than the condition itself."

Kff Health News

May 20, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Conexiant

May 20, 2026

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

Conexiant

May 18, 2026

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

Conexiant

May 18, 2026

Blood Test Predicts Immunotherapy Response

AI-based analysis of blood DNA maps the complex ecosystem surrounding cancer cells

The Pathologist

Ivarmacitinib Eased Refractory PCA: Case Report

Latest Headlines

FDA Expands Guselkumab Label in PsA

Medical Oddities: Can a Home Be Preventive Care?

Biologics Commonly Used in Cutaneous Crohn's Disease

AD Not Linked to Early CV Risk Markers

Biologics Commonly Used in Cutaneous Crohn Disease

Daily News

3 Medical Routines That Older People May Not Need

Combination Therapy Shows Potential in Psoriasis, Obesity

Ivarmacitinib Eased Refractory PCA: Case Report

FDA Clears Golimumab Biosimilars

Blood Test Predicts Immunotherapy Response

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Ivarmacitinib Eased Refractory PCA: Case Report

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Latest Headlines

Daily News

Recommendations